Hypoxia-inducible factor 1-regulated lysyl oxidase is involved in Staphylococcus aureus abscess formation

Infection and Immunity

Volumn 81, Issue 7, 2013, Pages 2562-2573

  Beerlage, Christiane ^a   Greb, Jessica ^a   Kretschmer, Dorothee ^b   Assaggaf, Mohammad ^c   Trackman, Philip C ^c   Hansmann, Martin Leo ^a   Bonin, Michael ^b   Eble, Johannes A ^a   Peschel, Andreas ^b   Brüne, Bernhard ^d   Kempf, Volkhard A J ^a  

^a UNIVERSITY HOSPITAL FRANKFURT   (Germany)

^b UNIVERSITY OF TÜBINGEN   (Germany)

^c BOSTON UNIVERSITY   (United States)

^d GOETHE UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

3 AMINOPROPIONITRILE; COLLAGEN; HYPOXIA INDUCIBLE FACTOR 1; PROTEIN LYSINE 6 OXIDASE;

ABSCESS; ANIMAL TISSUE; ARTICLE; BACTERIAL GROWTH; BACTERIAL LOAD; CELL CULTURE; CONTROLLED STUDY; CROSS LINKING; EXTRACELLULAR MATRIX; GENETIC TRANSCRIPTION; HISTOLOGY; HOST CELL; HOST PATHOGEN INTERACTION; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; KIDNEY ABSCESS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN STABILITY; SKIN BIOPSY; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS INFECTION;

ABSCESS; AMINOPROPIONITRILE; ANIMALS; BACTERIAL LOAD; DISEASE MODELS, ANIMAL; EXTRACELLULAR MATRIX PROTEINS; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; HEP G2 CELLS; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; IMMUNOHISTOCHEMISTRY; KERATINOCYTES; KIDNEY; MICE; PROTEIN-LYSINE 6-OXIDASE; SKIN; STAPHYLOCOCCAL INFECTIONS;

EID: 84879457089     PISSN: 00199567     EISSN: 10985522     Source Type: Journal    
DOI: 10.1128/IAI.00302-13     Document Type: Article

References (70)

1. Semenza GL. 2011. Regulation of metabolism by hypoxia-inducible factor Cold Spring Harbor Symp. Quant. Biol. 76:347-353.
2. Weidemann A, Johnson RS. 2008. Biology of HIF-1α. Cell Death Differ. 15:621-627.
3. Imtiyaz HZ, Simon MC. 2010. Hypoxia-inducible factors as essential regulators of inflammation. Curr. Top. Microbiol. Immunol. 345:105- 120.
4. Nizet V, Johnson RS. 2009. Interdependence of hypoxic and innate immune responses. Nat. Rev. Immunol. 9:609-617.
5. Pugh CW, Ratcliffe PJ. 2003. Regulation of angiogenesis by hypoxia: role of the HIF system. Nat. Med. 9:677-684.
6. Ivan M, Kondo K, Yang H, Kim W, Valiando J, Ohh M, Salic A, Asara JM, Lane WS, Kaelin WG, Jr. 2001. HIF_ targeted for VHL-mediated destruction by proline hydroxylation: implications forO2 sensing. Science 292:464-468.
7. Kempf VA, Lebiedziejewski M, Alitalo K, Wälzlein JH, Ehehalt U, Fiebig J, Huber S, Schütt B, Sander CA, Müller S, Grassl G, Yazdi AS, Brehm B, Autenrieth IB. 2005. Activation of hypoxia-inducible factor-1 in bacillary angiomatosis: evidence for a role of hypoxia-inducible factor-1 in bacterial infections. Circulation 111:1054-1062.
8. Werth N, Beerlage C, Rosenberger C, Yazdi AS, Edelmann M, Amr A, Bernhardt W, von Eiff C, Becker K, Schäfer A, Peschel A, Kempf VA. 2010. Activation of hypoxia inducible factor 1 is a general phenomenon in infections with human pathogens. PLoS One 5:e11576. doi:10.1371/journal.pone .0011576.
9. Riess T, Andersson SG, Lupas A, Schaller M, Schäfer A, Kyme P, Martin J, Wälzlein JH, Ehehalt U, Lindroos H, Schirle M, Nordheim A, Autenrieth IB, Kempf VA. 2004. Bartonella adhesin A mediates a proangiogenic host cell response. J. Exp. Med. 200:1267-1278.
10. Hartmann H, Eltzschig HK, Wurz H, Hantke K, Rakin A, Yazdi AS, Matteoli G, Bohn E, Autenrieth IB, Karhausen J, Neumann D, Colgan SP, Kempf VA. 2008. Hypoxia-independent activation of HIF-1 by Enterobacteriaceae and their siderophores. Gastroenterology 134:756-767.
11. Frede S, Stockmann C, Freitag P, Fandrey J. 2006. Bacterial lipopolysaccharides induce HIF-1 activation in human monocytes via p44/42 MAPK and NF-_B. Biochem. J. 396:517-527.
12. Rupp J, Gieffers J, Klinger M, van Zandbergen G, Wrase R, Maass M, Solbach W, Deiwick J, Hellwig-Bürgel T. 2007. Chlamydia pneumoniae directly interferes with HIF-1α stabilization in human host cells. Cell. Microbiol. 9:2181-2191.
13. Peyssonnaux C, Datta V, Cramer T, Doedens A, Theodorakis EA, Gallo RL, Hurtado-Ziola N, Nizet V, Johnson RS. 2005. HIF-1α expression regulates the bactericidal capacity of phagocytes. J. Clin. Invest. 115:1806- 1815.
14. Cramer T, Yamanishi Y, Clausen BE, Forster I, Pawlinski R, Mackman N, Haase VH, Jaenisch R, Corr M, Nizet V, Firestein GS, Gerber HP, Ferrara N, Johnson RS. 2003. HIF-1α is essential for myeloid cellmediated inflammation. Cell 112:645-657.
15. Peyssonnaux C, Cejudo-Martin P, Doedens A, Zinkernagel AS, Johnson RS, Nizet V. 2007. Essential role of hypoxia inducible factor-1α in development of lipopolysaccharide-induced sepsis. J. Immunol. 178:7516-7519.
16. Lowy FD. 1998. Staphylococcus aureus infections. N. Engl. J. Med. 339: 520-532.
17. Cheng AG, Dent AC, Schneewind O, Missiakas D. 2011. A play in four acts: Staphylococcus aureus abscess formation. Trends Microbiol. 19:225-232.
18. Flaris NA, Hickey WF. 1992. Development and characterization of an experimental model of brain abscess in the rat. Am. J. Pathol. 141:1299- 1307.
19. Lam GT, Sweeney FJ, Jr, Witmer CM, Wise RI. 1963. Abscess-forming factor(s) produced by Staphylococcus aureus. I. Collodion bag implantation technique. J. Bacteriol. 86:611-615.
20. Freedlander SO, Toomey JA. 1928. The role of clasmatocytes and connective tissue cells in non-specific local cutaneous immunity to Staphylococcus. J. Exp. Med. 47:663-675.
21. Erler JT, Bennewith KL, Nicolau M, Dornhofer N, Kong C, Le QT, Chi JT, Jeffrey SS, Giaccia AJ. 2006. Lysyl oxidase is essential for hypoxiainduced metastasis. Nature 440:1222-1226.
22. Kagan HM, Li W. 2003. Lysyl oxidase: properties, specificity, and biological roles inside and outside of the cell. J. Cell. Biochem. 88:660-672.
23. Lazarus HM, Cruikshank WW, Narasimhan N, Kagan HM, Center DM. 1995. Induction of human monocyte motility by lysyl oxidase. Matrix Biol. 14:727-731.
24. Nelson JM, Diegelmann RF, Cohen IK. 1988. Effect of betaaminopropionitrile and ascorbate on fibroblast migration. Proc. Soc. Exp. Biol. Med. 188:346-352.
25. Li W, Liu G, Chou IN, Kagan HM. 2000. Hydrogen peroxide-mediated, lysyl oxidase-dependent chemotaxis of vascular smooth muscle cells. J. Cell. Biochem. 78:550-557.
26. Sommer P, Gleyzal C, Raccurt M, Delbourg M, Serrar M, Joazeiro P, Peyrol S, Kagan H, Trackman PC, Grimaud JA. 1993. Transient expression of lysyl oxidase by liver myofibroblasts in murine schistosomiasis. Lab. Invest. 69:460-470.
27. Guerret S, Vuitton DA, Liance M, Pater C, Carbillet JP. 1998. Echinococcus multilocularis: relationship between susceptibility/resistance and liver fibrogenesis in experimental mice. Parasitol. Res. 84:657-667.
28. Morawietz L, Weimann A, Schroeder JH, Kuban RJ, Ungethuem U, Kaps C, Slevogt H, Gehrke T, Krukemeyer MG, Krenn V. 2008. Gene expression in endoprosthesis loosening: chitinase activity for early diagnosis? J. Orthop. Res. 26:394-403.
29. Novick R. 1967. Properties of a cryptic high-frequency transducing phage in Staphylococcus aureus. Virology 33:155-166.
30. Berscheid A, Sass P, Weber-Lassalle K, Cheung AL, Bierbaum G. 2012. Revisiting the genomes of the Staphylococcus aureus strains NCTC 8325 and RN4220. Int. J. Med. Microbiol. 302:84-87.
31. von Eiff C, McNamara P, Becker K, Bates D, Lei XH, Ziman M, Bochner BR, Peters G, Proctor RA. 2006. Phenotype microarray profiling of Staphylococcus aureus menD and hemB mutants with the smallcolony-variant phenotype. J. Bacteriol. 188:687-693.
32. Menrad H, Werno C, Schmid T, Copanaki E, Deller T, Dehne N, Brüne B. 2010. Roles of hypoxia-inducible factor-1α (HIF-1α) versus HIF-2_ in the survival of hepatocellular tumor spheroids. Hepatology 51:2183-2192.
33. Schmittgen TD, Livak KJ. 2008. Analyzing real-time PCR data by the comparative CT method. Nat. Protoc. 3:1101-1108.
34. Kurz A, Rabbani N, Walter M, Bonin M, Thornalley P, Auburger G, Gispert S. 2011. Alpha-synuclein deficiency leads to increased glyoxalase I expression and glycation stress. Cell. Mol. Life Sci. 68:721-733.
35. Eliades A, Papadantonakis N, Bhupatiraju A, Burridge KA, Johnston-Cox HA, Migliaccio AR, Crispino JD, Lucero HA, Trackman PC, Ravid K. 2011. Control of megakaryocyte expansion and bone marrow fibrosis by lysyl oxidase. J. Biol. Chem. 286:27630-27638.
36. Higgins DF, Kimura K, Bernhardt WM, Shrimanker N, Akai Y, Hohenstein B, Saito Y, Johnson RS, Kretzler M, Cohen CD, Eckardt KU, Iwano M, Haase VH. 2007. Hypoxia promotes fibrogenesis in vivo via HIF-1 stimulation of epithelial-to-mesenchymal transition. J. Clin. Invest. 117:3810-3820.
37. Reischl U, Linde HJ, Metz M, Leppmeier B, Lehn N. 2000. Rapid identification of methicillin-resistant Staphylococcus aureus and simultaneous species confirmation using real-time fluorescence PCR. J. Clin. Microbiol. 38:2429-2433.
38. Hurtado PA, Vora S, Sume SS, Yang D, St Hilaire C, Guo Y, Palamakumbura AH, Schreiber BM, Ravid K, Trackman PC. 2008. Lysyl oxidase propeptide inhibits smooth muscle cell signaling and proliferation. Biochem. Biophys. Res. Commun. 366:156-161.
39. Tang SS, Trackman PC, Kagan HM. 1983. Reaction of aortic lysyl oxidase with beta-aminopropionitrile. J. Biol. Chem. 258:4331-4338.
40. Eltzschig HK, Carmeliet P. 2011. Hypoxia and inflammation. N. Engl. J. Med. 364:656-665.
41. Jonkam CC, Bansal K, Traber DL, Hamahata A, Maybauer MO, Maybauer DM, Cox RA, Lange M, Connelly RL, Traber LD, Djukom CD, Salsbury JR, Herndon DN, Enkhbaatar P. 2009. Pulmonary vascular permeability changes in an ovine model of methicillin-resistant Staphylococcus aureus sepsis. Crit. Care 13:R19. doi:10.1186/cc7720.
42. Carmeliet P. 2005. VEGF as a key mediator of angiogenesis in cancer. Oncology 69(Suppl. 3):4 -10.
43. Kagan HM. 2000. Intra- and extracellular enzymes of collagen biosynthesis as biological and chemical targets in the control of fibrosis. Acta Trop. 77:147-152.
44. Mäki JM. 2009. Lysyl oxidases in mammalian development and certain pathological conditions. Histol. Histopathol. 24:651-660.
45. Kagan HM. 1994. Lysyl oxidase: mechanism, regulation and relationship to liver fibrosis. Pathol. Res. Pract. 190:910-919.
46. Mormone E, George J, Nieto N. 2011. Molecular pathogenesis of hepatic fibrosis and current therapeutic approaches. Chem. Biol. Interact. 193: 225-231.
47. Vanfleteren LE, Linssen CF. 2010. Role of microorganisms in interstitial lung disease. Curr. Opin. Pulm. Med. 16:489-495.
48. Andrade ZA. 2009. Schistosomiasis and liver fibrosis. Parasite Immunol. 31:656-663.
49. Halberg N, Khan T, Trujillo ME, Wernstedt-Asterholm I, Attie AD, Sherwani S, Wang ZV, Landskroner-Eiger S, Dineen S, Magalang UJ, Brekken RA, Scherer PE. 2009. Hypoxia-inducible factor 1α induces fibrosis and insulin resistance in white adipose tissue. Mol. Cell. Biol. 29:4467-4483.
50. Ellisen LW. 2005. Growth control under stress: mTOR regulation through the REDD1-TSC pathway. Cell Cycle 4:1500-1502.
51. Bartrons R, Caro J. 2007. Hypoxia, glucose metabolism and the Warburg's effect. J. Bioenerg. Biomembr. 39:223-229.
52. Semenza GL. 2010. HIF-1: upstream and downstream of cancer metabolism. Curr. Opin. Genet. Dev. 20:51-56.
53. Mollicone R, Moore SE, Bovin N, Garcia-Rosasco M, Candelier JJ, Martinez-Duncker I, Oriol R. 2009. Activity, splice variants, conserved peptide motifs, and phylogeny of two new_1,3-fucosyltransferase families (FUT10 and FUT11). J. Biol. Chem. 284:4723-4738.
54. Shen GM, Zhang FL, Liu XL, Zhang JW. 2010. Hypoxia-inducible factor 1-mediated regulation of PPP1R3C promotes glycogen accumulation in human MCF-7 cells under hypoxia. FEBS Lett. 584:4366-4372.
55. Bellot G, Garcia-Medina R, Gounon P, Chiche J, Roux D, Pouyssegur J, Mazure NM. 2009. Hypoxia-induced autophagy is mediated through hypoxia-inducible factor induction of BNIP3 and BNIP3L via their BH3 domains. Mol. Cell. Biol. 29:2570-2581.
56. Aminova LR, Siddiq A, Ratan RR. 2008. Antioxidants, HIF prolyl hydroxylase inhibitors or short interfering RNAs to BNIP3 or PUMA, can prevent prodeath effects of the transcriptional activator, HIF-1α, in a mouse hippocampal neuronal line. Antioxid. Redox. Signal. 10:1989- 1998.
57. del Peso L, Castellanos MC, Temes E, Martin-Puig S, Cuevas Y, Olmos G, Landazuri MO. 2003. The von Hippel Lindau/hypoxia-inducible factor (HIF) pathway regulates the transcription of the HIF-proline hydroxylase genes in response to low oxygen. J. Biol. Chem. 278:48690-48695.
58. Rodriguez C, Martinez-Gonzalez J, Raposo B, Alcudia JF, Guadall A, Badimon L. 2008. Regulation of lysyl oxidase in vascular cells: lysyl oxidase as a new player in cardiovascular diseases. Cardiovasc. Res. 79:7-13.
59. Carmeliet P, Dor Y, Herbert JM, Fukumura D, Brusselmans K, Dewerchin M, Neeman M, Bono F, Abramovitch R, Maxwell P, Koch CJ, Ratcliffe P, Moons L, Jain RK, Collen D, Keshert E. 1998. Role of HIF-1α in hypoxia-mediated apoptosis, cell proliferation and tumour angiogenesis. Nature 394:485-490.
60. Schödel J, Oikonomopoulos S, Ragoussis J, Pugh CW, Ratcliffe PJ, Mole DR. 2011. High-resolution genome-wide mapping of HIF-binding sites by ChIP-seq. Blood 117:e207- e217.
61. Xia X, Lemieux ME, Li W, Carroll JS, Brown M, Liu XS, Kung AL. 2009. Integrative analysis of HIF binding and transactivation reveals its role in maintaining histone methylation homeostasis. Proc. Natl. Acad. Sci. U. S. A. 106:4260-4265.
62. Aprelikova O, Wood M, Tackett S, Chandramouli GV, Barrett JC. 2006. Role of ETS transcription factors in the hypoxia-inducible factor-2 target gene selection. Cancer Res. 66:5641-5647.
63. Togashi A, Katagiri T, Ashida S, Fujioka T, Maruyama O, Wakumoto Y, Sakamoto Y, Fujime M, Kawachi Y, Shuin T, Nakamura Y. 2005. Hypoxia-inducible protein 2 (HIG2), a novel diagnostic marker for renal cell carcinoma and potential target for molecular therapy. Cancer Res. 65:4817-4826.
64. Gimm T, Wiese M, Teschemacher B, Deggerich A, Schödel J, Knaup KX, Hackenbeck T, Hellerbrand C, Amann K, Wiesener MS, Höning S, Eckardt KU, Warnecke C. 2010. Hypoxia-inducible protein 2 is a novel lipid droplet protein and a specific target gene of hypoxia-inducible factor- FASEB J. 24:4443-4458.
65. Chang BH, Chan L. 2007. Regulation of triglyceride metabolism. III. Emerging role of lipid droplet protein ADFP in health and disease. Am. J. Physiol. Gastrointest. Liver Physiol. 292:G1465-G1468.
66. Chang AC, Jellinek DA, Reddel RR. 2003. Mammalian stanniocalcins and cancer. Endocr. Relat. Cancer 10:359-373.
67. Law AY, Wong CK. 2010. Stanniocalcin-2 is a HIF-1 target gene that promotes cell proliferation in hypoxia. Exp. Cell Res. 316:466-476.
68. Warnecke C, Weidemann A, Volke M, Schietke R, Wu X, Knaup KX, Hackenbeck T, Bernhardt W, Willam C, Eckardt KU, Wiesener MS. 2008. The specific contribution of hypoxia-inducible factor-2_ to hypoxic gene expression in vitro is limited and modulated by cell type-specific and exogenous factors. Exp. Cell Res. 314:2016-2027.
69. Furney SJ, Simmons A, Breen G, Pedroso I, Lunnon K, Proitsi P, Hodges A, Powell J, Wahlund LO, Kloszewska I, Mecocci P, Soininen H, Tsolaki M, Vellas B, Spenger C, Lathrop M, Shen L, Kim S, Saykin AJ, Weiner MW, Lovestone S. 2011. Genome-wide association with MRI atrophy measures as a quantitative trait locus for Alzheimer's disease. Mol. Psychiatry 16:1130-1138.
70. Wan J, Ma J, Mei J, Shan G. 2009. The effects of HIF-1α on gene expression profiles of NCI-H446 human small cell lung cancer cells. J. Exp. Clin. Cancer Res. 28:150. doi:10.1186/1756-9966-28-150.